StockWatch
·

Synergy Green Industries Ltd Q1 FY27 Results

SGILQ1 FY27 Results
Filing
Result:Poor· Market: CrashedMargin squeeze

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValuevs Q4 FY26
Revenue75.15 Cr36.9%
Total Income75.71 Cr38.7%
Expenditure86.40 Cr29.8%
PBT-10.69 Cr3546.0%
Net Profit-10.11 Cr2581.5%
OPM6.30%2.45pp
NPM-13.35%13.68pp
EPS6.512403.8%
View full financials

Revenue fell 10.1% YoY, OPM more than halved to 6.3% from 13.6%, and the company swung from a ₹3.4cr profit to a ₹10.1cr net loss — clear deterioration, not a turnaround.

SYNERGY GREEN INDUSTRIES · Q1 FY-2027 · THE VERDICT

Production up 10%, sales down 10%: the capacity ramp that never arrived

Synergy Green expanded its foundry to 45,000 tons and immediately posted a ₹10.1 crore loss. Management blames shipping delays and prototype approvals; the production-sales mismatch suggests deeper execution risk.

18 Aug 2026 · 6 min read

Synergy Green Industries closed Q1 FY-2027 with a ₹10.1 crore loss and 10.1% revenue decline, despite a fresh 45,000-ton foundry running at only 66% utilization. The paradox is stark: production was up 10% year-on-year, but sales fell 10%. Everything made did not sell, management said, because of West Asia shipping constraints and customer prototype approval delays. That framing — that the gap is logistical, not demand — is the crux of the quarter and the credibility test going forward.

Revenue delivered

₹75.1 Cr

-10.1% YoY; Q1 already signals miss on ₹500 Cr FY27 guidance

Net profit

-₹10.1 Cr

-399% YoY; operational loss before one-time items

PBDIT margin

7%

needs 16%+ for 300bp guidance; ₹600 Cr headwind cited

Capacity utilization

66%

of 45,000-ton foundry; July hit 85% per management

Where the quarter went wrong

Synergy Green listed ₹600 crore in margin headwinds for Q1: raw materials down 200 basis points (pig iron, CRC inflation), consumables down 300 basis points (Furan Resin +60% from crude spike), and electricity down 100 basis points. Of this, management claims only ~200 basis points is recoverable in Q2 via indexed pass-through to customers (with a one-quarter lag). The arithmetic alone tells the story: a gap of ₹200–300 crore in unresolved headwinds, yet the company is still targeting 300 basis point margin expansion for the full year. Other income of ₹4.4 crore — forex gains and export incentives — masks the operational loss, which was negative.

Everything produced was not sold, leading to an increase in inventory due to shipping constraints and prototype approvals.

Management's claims vs. what holds up

  • "Production up 10% YoY despite capacity headwinds"

  • "300 basis point margin expansion is targeted for FY27"

  • "₹600 Cr margin headwinds are majorly recoverable"

  • "₹500 Cr executable order book supports FY27 guidance"

  • "Nordex 5MW and Vestas 4MW represent significant new capacity absorption"

  • "Margin recovery via indexation and operational efficiency is on track"

Contradicted: Production up 10% is fact; but sales down 10% signals that the production gain was inventory buildup. If external constraints (shipping, approvals) were the only issue, production would have been cautious, not aggressive. Management built ahead of demand. Overstated: The 300 basis point expansion needs to overcome 600 basis point headwinds. Only 200 basis points claimed recoverable (Q2+). Company is betting on ~100 basis points from volume leverage and efficiency. That leverage is absent in Q1; capacity at 66% offers room, but execution risk is high. Partial: The 600 basis point headwind is real and itemized. Recovery is real but partial and lagged. Transparency on headwinds, but optimistic on timing. Overstated: Order book was previously referenced as ₹600–700 crore. Now positioned as ₹500 crore "executable" for FY27; balance pushed to FY28 with higher capacity. No explicit downgrade was acknowledged. This is a soft reframing of execution risk. Supported: Nordex 5MW samples approved; Vestas 4MW contract signed. These are real wins but both sample/ramp outside the FY27 guidance window (Vestas samples Q4 FY27, production Q1 FY28). Overstated: Margin recovery math doesn't reconcile 300 basis point target against 600 basis point headwinds with only 200 basis points quantifiably recoverable. Timeline speculative.

What changed on this call

Shifts from prior positioning

Order book

Q1 FY-2027

₹500 Cr 'executable' for FY27; ₹600 Cr potential in FY28 with higher capacity

Implication

Soft downgrade; execution hurdles acknowledged but not directly named

₹600–700 Cr reference

Vestas concentration

Q1 FY-2027

Targeting 30% via Nordex, Adani, Siemens each allocating ₹100–150 Cr

Implication

Diversification strategy confirmed; dependent on new customer ramps; execution lagging

Historically 40–45% of revenue

Non-wind segment

Q1 FY-2027

L&T coal-plant castings, BHEL power sector, Terex mining (Yen/Rupee +20%)

Implication

Addressable market expanding; new 8–9 month development cycles introduce timing risk

Gearbox only

Capacity utilization

Q1 FY-2027

Q1 at 66%; July touched 85% (management verbal claim, unaudited)

Implication

Momentum narrative stated; Q2 run-rate critical to validate

Ramp trajectory to be proven

Earnings quality flags

The bull-bear ledger

  • Wind demand is structurally strong (India targeting 77 GW by 2030; global growth 5.2% CAGR)

  • Synergy is top-3 foundry to major OEMs; 15-year Vestas relationship is a moat

  • Nordex 5MW approval and Vestas 4MW contract are real wins; non-wind (L&T, BHEL) diversifies

  • Yen/Rupee +20% tailwind vs. China on mining castings expands addressable market

  • Q1 revenue decline of 10.1% contradicts 33% FY27 guidance; ₹500 Cr pace now impossible

  • Unprofitable start (₹10.1 Cr loss) undermines 300 basis point margin expansion credibility

  • Order book softly downgraded (₹600–700 → ₹500 Cr); new customer ramps slip to FY28

  • Production-sales mismatch signals execution lag, not just external delays; inventory risk

  • Commodity and energy headwind recovery is partial and lagged; unresolved gap remains

  • Management tone is defensive; reframed claims without direct acknowledgment of misses

Risks, ranked by holder concern

1

High
Risk

Profitability and solvency: operating loss in Q1 amid capacity expansion

Why it matters

Net loss ₹10.1 Cr, NPM −13.3%. Company unprofitable despite new capacity online. Inventory buildup and sales lag threaten margin recovery. If Q2 also misses, covenant/refinancing risk emerges.

2

High
Risk

Revenue execution: production-sales mismatch signals demand timing risk

Why it matters

Production +10% but sales −10.1% YoY. Management cites external delays, but buildup indicates over-confidence. If offtake remains slow, ₹500 Cr FY27 target is unreachable.

3

High
Risk

Margin credibility: 300 basis point guidance vs. 600 basis point headwinds with partial recovery

Why it matters

Management claims 300 basis point expansion but itemizes 600 basis point headwinds and only resolves 200 basis points in Q2. Gap of 200–300 basis points unresolved. If volume leverage doesn't materialize, guidance misses again.

4

Medium
Risk

Customer concentration and new OEM execution: Vestas 40–45% of revenue; new customer ramps slip

Why it matters

Vestas dominance creates concentration. Diversification via Nordex, Adani, Siemens is the plan but Vestas 4MW samples deferred to Q4 FY27 (outside guidance window). Execution risk is high.

5

Medium
Risk

Commodity and energy inflation: pass-through lag and partial recovery

Why it matters

Furan Resin +60%, pig iron/CRC inflation, PNG/LNG +60–70%. Pass-through lags by one quarter. Only 200 basis points of 600 basis points recoverable in Q2. If commodities stay elevated, margin squeeze persists.

6

Medium
Risk

Capacity constraint on large castings: Adani 5MW, offshore blocked

Why it matters

Current foundry has 30-ton casting limit. Adani 5MW parts exceed this; China imports needed. Offshore (5–10+ MW) requires infrastructure absent in India. Addressable market capped until ₹100,000-ton expansion (Dec 2027 / Mar 2028 land acquisition, FY28 capex).

How the street is positioned

Price action and trend. Stock is trading at ₹551 as of 2026-08-18, up 5.27% on day 1 post-result from pre-result close of ₹538.75. The one-day pop is a relief rally — market was braced for worse. However, stock remains 12.57% below its all-time high and trades below SMA20 (₹589.14) and SMA50 (₹584.22), while above SMA200 (₹540.76). RSI 37.5 is neutral-to-weak. Volume is trending higher, suggesting retail interest. Over 52 weeks, range is ₹420–₹630.2; at ₹551 the stock is 31% off lows but still 12.57% below peak.

Institutional positioning: FII and DII. Institutional interest is minimal. FII holdings are 0.23% (unchanged), DII 1.73% (up 22 basis points QoQ). Promoters dominate at 69.50%, unchanged. Narrow float and weak institutional participation mean the stock is sensitive to retail flows. Absence of FII adds execution risk; if story sours, there is no institutional bid to support the price.

The verdict on the pop. The 5.27% day-1 rally is relief on "not bankrupt." The stock remains below key moving averages and has not attracted institutional money. For a holder nursing a 12.57% drawdown from ATH, this pop is a reassessment moment, not celebration. For new money, the setup remains weak: execution risk is proven, guidance is non-credible, and there is no institutional support to stabilize the stock if Q2 disappoints.

The debate

What to watch next

  • 1 · Q2 FY-2027 run-rate: Do margins recover as claimed?

    Q2 will test claims on cost pass-through recovery and volume leverage. If PBDIT margin is still <10%, the 16%+ target and 300 basis point guidance are dead. Watch for production-sales alignment: if production remains ahead of sales, inventory risk deepens.

  • 2 · Capacity utilization trajectory through H2 FY27

    July hit 85% per verbal management claim (unaudited). Sustaining 75–80%+ is critical. If utilization slips back to 66–70%, volume leverage disappears and margin recovery is impossible. Primary operational metric.

  • 3 · New customer sample approvals and shipment pace

    Vestas 4MW samples Q4 FY27, Nordex orders ramping. Are delays genuinely easing? If these slip further into FY28, ₹500 Cr revenue target is unreachable. Press for monthly offtake run-rates.

  • 4 · FY-2027 full-year guidance walk (or reaffirm)

    If Q2 revenue misses >5% again, management will need to lower FY27 guidance. Any walk below ₹450 Cr signals execution is fundamentally broken, not cyclically delayed. This is the credibility test.

The number to track

PBDIT margin, quarterly. Q1 was 7%. Management says 16%+ is achievable by year-end. That requires ₹5.3 crore PBDIT scaling to ~₹12 crore in subsequent quarters (assuming ₹75 Cr revenue runs). If Q2–Q4 PBDIT is still <₹8–9 crore, the guidance is a fantasy. Track the absolute PBDIT figure; ignore management rhetoric.

Synergy Green Industries has the right foundry, the right OEM relationships, and the right end-market tailwinds. But it fumbled the execution on day one. A 10% revenue decline in a company guiding 33% growth, while running new capacity at 66% utilization and bleeding cash, is not a logistics glitch. It is a pause. Management has reframed claims (order book, margin recovery) without directly admitting misses. Institutional investors are absent (FII 0.23%). The stock is down 12.57% from ATH.

The case for a Hold is that wind demand is real, new customers are real, and one quarter of stumbling doesn't negate structural growth. The case for a Reduce is that execution risk is proven, guidance credibility is destroyed, and the margin math doesn't reconcile. The next two quarters will determine which story wins. For now, Synergy Green is a speculative, illiquid story with high downside if Q2 disappoints — and high upside if the company finally executes. The honest read: hold existing positions, avoid new money unless you can stomach a 20%+ drawdown. Track PBDIT margin, capacity utilization, and FY27 revenue run-rate monthly. The company is not broken, but it is on probation.

Informational and educational content only. Not investment advice.

Synergy Green Industries Ltd (SGIL) Q1 FY27 Results, Transcript & Analysis — StockWatch